Ormat Technologies, Inc. (ORA) is up 7.3% today. Here is some analysis on what might have caused this price movement.
Analysis: The move higher appears tied to Ormat’s first-quarter 2026 earnings release, which highlighted a large year-over-year revenue increase and a sizable rise in adjusted EBITDA. Investors may also be responding to management’s discussion of improved segment mix (notably energy storage and products), solid backlog commentary, and prior financing actions that extended the company’s maturity profile.
Details:
Sources:
GlobeNewswire, U.S. Securities and Exchange Commission, Ormat Investor Relations
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ORA Insider Trading Activity
$ORA insiders have traded $ORA stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $ORA stock by insiders over the last 6 months:
- ASSI GINZBURG (Chief Financial Officer) sold 20,000 shares for an estimated $2,254,500
- ISAAC ANGEL sold 18,018 shares for an estimated $2,025,668
- JESSICA WOELFEL (GC, CCO, and CS) has made 0 purchases and 8 sales selling 8,380 shares for an estimated $910,079.
- RAVIT BARNIV sold 1,753 shares for an estimated $197,282
- OFER BENYOSEF (EVP, Energy Storage & BD) sold 511 shares for an estimated $57,896
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$ORA Hedge Fund Activity
We have seen 195 institutional investors add shares of $ORA stock to their portfolio, and 177 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IMPAX ASSET MANAGEMENT GROUP PLC removed 1,086,369 shares (-61.6%) from their portfolio in Q4 2025, for an estimated $120,011,183
- AMUNDI removed 590,007 shares (-55.0%) from their portfolio in Q4 2025, for an estimated $65,178,073
- MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. added 540,000 shares (+155.8%) to their portfolio in Q4 2025, for an estimated $59,653,800
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 453,415 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $50,088,755
- ZURCHER KANTONALBANK (ZURICH CANTONALBANK) added 358,655 shares (+825.8%) to their portfolio in Q4 2025, for an estimated $39,620,617
- JPMORGAN CHASE & CO removed 350,211 shares (-68.8%) from their portfolio in Q4 2025, for an estimated $38,687,809
- WELLINGTON MANAGEMENT GROUP LLP added 336,847 shares (+inf%) to their portfolio in Q4 2025, for an estimated $37,211,488
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$ORA Analyst Ratings
Wall Street analysts have issued reports on $ORA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/15/2026
- TD Cowen issued a "Buy" rating on 01/09/2026
To track analyst ratings and price targets for $ORA, check out Quiver Quantitative's $ORA forecast page.
$ORA Price Targets
Multiple analysts have issued price targets for $ORA recently. We have seen 10 analysts offer price targets for $ORA in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Mark Strouse from JP Morgan set a target price of $106.0 on 04/16/2026
- Christopher Dendrinos from RBC Capital set a target price of $130.0 on 03/03/2026
- Jon Windham from UBS set a target price of $143.0 on 03/03/2026
- David Anderson from Barclays set a target price of $123.0 on 03/02/2026
- Ben Kallo from Baird set a target price of $130.0 on 02/27/2026
- Ryan Levine from Citigroup set a target price of $128.0 on 02/18/2026
- Julien Dumoulin-Smith from Jefferies set a target price of $130.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.